|
|
||||||||
From the Departments of Paediatrics (Neurology) (B.B.) and Diagnostic Imaging (M.S.), The Hospital for Sick Children, Toronto, Canada; Division of Pediatric Neurology (J.N.), University of Alabama at Birmingham; Wake Forest University School of Medicine (D.J.), NC; Department of Neurology (S.S.), University of Rochester, NY; and Baird MS Center (B.W.-G.), Jacobs Neurological Institute, Buffalo, NY.
Address correspondence and reprint requests to Dr. Brenda Banwell, The Hospital for Sick Children, 555 University Ave., 6th Floor, Toronto, ON Canada M5G 1X8; e-mail: brenda.banwell{at}sickkids.ca
Background: MRI has revolutionized the diagnostic accuracy of multiple sclerosis (MS) in adults, and is now used extensively to evaluate efficacy of immunomodulatory therapies. Although MRI has also been used to aid in the diagnosis and care of children with MS, the MRI features of MS in children are less well understood.
Methods: The present review summarizes the available literature on MRI in pediatric MS, outlines the specific features of other disorders affecting the CNS white matter in children, compares the MRI appearance of MS in children to seminal neuroimaging studies in adult-onset MS, and discusses the potential role of advanced MRI technologies in delineating the underlying pathobiology of acquired demyelinating disease in children.
Results: Although the MRI features of MS in children have similarity to adult-onset MS, children tend to have fewer lesions and a lower propensity for lesions to enhance with gadolinium. The MRI findings in children presenting with a clinical phenotype of acute disseminated encephalomyelitis may be indistinguishable from the first attack of MS.
Conclusions: MRI criteria specific for pediatric-onset multiple sclerosis (MS) and criteria predictive of MS outcome in children experiencing a first demyelinating event will be challenged by the overlap in MRI features between acute monophasic demyelinating syndromes and MS, particularly in younger children. Emergence of new clinically silent lesions on MRI scans separated by at least 3 months is characteristic of MS. Newer MRI techniques evaluating white matter biochemistry and integrity in the youngest MS patients may provide new insights into the relative contributions of inflammation and neurodegeneration in MS.
*Members of the International Pediatric MS Study Group are listed in the Appendix.
Disclosure: The authors report no conflicts of interest.
This article has been cited by other articles:
![]() |
D. Miller, B. Weinshenker, M Filippi, B. Banwell, J. Cohen, M. Freedman, S. Galetta, M Hutchinson, R. Johnson, L Kappos, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach Multiple Sclerosis, November 1, 2008; 14(9): 1157 - 1174. [Abstract] [PDF] |
||||
![]() |
R. F. Neuteboom, M. Boon, C. E. Catsman Berrevoets, J. S. Vles, R. H. Gooskens, H. Stroink, R. J. Vermeulen, J. J. Rotteveel, I. A. Ketelslegers, E. Peeters, et al. Prognostic factors after a first attack of inflammatory CNS demyelination in children Neurology, September 23, 2008; 71(13): 967 - 973. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |